Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 7;8(7):209.
doi: 10.3390/toxins8070209.

Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis

Affiliations
Free PMC article
Review

Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis

Catherine Dunyach-Remy et al. Toxins (Basel). .
Free PMC article

Abstract

Infection of foot ulcers is a common, often severe and costly complication in diabetes. Diabetic foot infections (DFI) are mainly polymicrobial, and Staphylococcus aureus is the most frequent pathogen isolated. The numerous virulence factors and toxins produced by S. aureus during an infection are well characterized. However, some particular features could be observed in DFI. The aim of this review is to describe the role of S. aureus in DFI and the implication of its toxins in the establishment of the infection. Studies on this issue have helped to distinguish two S. aureus populations in DFI: toxinogenic S. aureus strains (harboring exfoliatin-, EDIN-, PVL- or TSST-encoding genes) and non-toxinogenic strains. Toxinogenic strains are often present in infections with a more severe grade and systemic impact, whereas non-toxinogenic strains seem to remain localized in deep structures and bone involving diabetic foot osteomyelitis. Testing the virulence profile of bacteria seems to be a promising way to predict the behavior of S. aureus in the chronic wounds.

Keywords: Staphylococcus aureus; diabetic foot infection; toxins.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Interactions between metabolic, anatomical and bacteriological factors in diabetic foot infection.
Figure 2
Figure 2
Worldwide geographic distribution of Gram-positive cocci (GP), S. aureus and Methicillin Resistant S. aureus (MRSA) isolated from diabetic foot ulcers. Red shading indicates regions where GP are predominant. Green shading indicates regions where Gram-negative bacilli are predominant.
Figure 3
Figure 3
Infection process and virulence factors of Staphylococcus aureus in diabetic foot infection; MSCRAMM: microbial surface components recognizing adhesive matrix molecules. S. aureus secretes several virulence factors that evade host immune defenses. α-hemolysin (or α-toxin), phenol-soluble modulins (PSMs) and Panton-Valentine leukocidin (PVL) have the capacity to lyse host cells, which is a mechanism to evade immune responses. In addition, S. aureus secretes factors that inhibit neutrophil function, such as chemotaxis inhibitory protein of staphylococci (CHIPS). In addition, S. aureus possesses factors that active lymphocyte T cells: the superantigens (SE: enterotoxins; SEI: enterotoxin-like protein; TSST: toxic shock-syndrome toxin). On the other side, exfoliative toxins (Ets) facilitate bacterial skin invasion.

Similar articles

Cited by

References

    1. Singh N., Armstrong D.G., Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–228. doi: 10.1001/jama.293.2.217. - DOI - PubMed
    1. Prompers L., Huijberts M., Schaper N., Apelqvist J., Bakker K., Edmonds M., Holstein P., Jude E., Jirkovska A., Mauricio D., et al. Resource utilisation and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study. Diabetologia. 2008;51:1826–1834. doi: 10.1007/s00125-008-1089-6. - DOI - PubMed
    1. Lipsky B.A., Berendt A.R., Deery H.G., Embil J.M., Joseph W.S., Karchmer A.W., LeFrock J.L., Lew D.P., Mader J.T., Norden C., et al. Diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 2004;39:885–910. doi: 10.1086/424846. - DOI - PubMed
    1. Lavery L.A., Armstrong D.G., Wunderlich R.P., Tredwell J., Boulton A.J. Diabetic foot syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–1438. doi: 10.2337/diacare.26.5.1435. - DOI - PubMed
    1. Jeffcoate W.J., Lipsky B.A., Berendt A.R., Cavanagh P.R., Bus S.A., Peters E.J., van Houtum W.H., Valk G., Bakker K. Unresolved issues in the management of ulcers of the foot in diabetes. Diabet. Med. 2008;25:1380–1389. doi: 10.1111/j.1464-5491.2008.02573.x. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources